Ototoxicity from intermittent streptoduocin therapy of pulmonary tuberculosis; a study of one hundred five patients treated eight to ten months.
D004096:Dihydrostreptomycin Sulfate / Q000009:adverse effects*; D006309:Hearing; D006311:Hearing Disorders / Q000209:etiology*; D006320:Hearing Tests; D006801:Humans; D013307:Streptomycin / Q000009:adverse effects*; D014397:Tuberculosis, Pulmonary
D004096:Dihydrostreptomycin Sulfate; D013307:Streptomycin
DIHYDROSTREPTOMYCIN/injurious effects; HEARING DISORDERS/etiology and pathogenesis; STREPTOMYCIN/injurious effects